Major studies confirm accurate non-invasive tests for diagnosing liver disease

Two major international studies have provided strong evidence identifying non-invasive tests that accurately diagnose and assess the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its severe form, MASH. This advancement reduces the need for invasive liver biopsies in clinical practice.

Originally published by gnews